Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Publikationen > 2014

Publikationen 2014

Dopfer EP, Hartl FA, Oberg HH, Siegers GM, Yousefi OS, Kock S, Fiala GJ, Garcillán B, Sandstrom A, Alarcón B, Regueiro JR, Kabelitz D, Adams EJ, Minguet S, Wesch D, Fisch P, Schamel WW. The CD3 conformational change in the  T cell receptor is not triggered by antigens but can be enforced to enhance tumor killing. Cell Rep 7:1704-1715, 2014

Ebsen H, Lettau M, Kabelitz D, Janssen O. Identification of SH3 domain proteins interacting with the cytoplasmic tail of the a disintegrin and metalloprotease 10 (ADAM10). PLoS One, 9:e102899, 2014

Fazio J, Kalyan S, Wesch D, Kabelitz D. Inhibition of human  T cell proliferation and effector functions by neutrophil serine proteases. Scand J Immunol 80:381-389, 2014

Fritsch J, Stephan M, Tchikov V, Winoto-Morbach S, Gubkina S, Kabelitz D, Schütze S. Cell fate decisions regulated by K63 ubiquitination of tumor necrosis factor receptor 1. Mol Cell Biol, 34:3214-3228, 2014

Gierloff M, Nitsche  T, Adam-Klages S, Liebs K, Hedderich J, Gassling V, Wiltfang J, Kabelitz D, Acil Y. In vitro comparison of different carrier materials with rat bone marrow MSCs. Clin Oral Invest, 18:247-259, 2014

Gierloff M, Petersen L, Oberg HH, Quabius ES, Wiltfang J, Acil Y. Adipogenic differentiation potential of rat adipose tissue derived subpopulations of stromal cells. J Plast Reconstr Aesthet Surg, 67:1427-1435

Grage-Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag-Wolf S, Goebel L, Vogel I, Becker T, Ebsen M, Röcken C, Altevogt P, Schumacher U, Schäfer H, Sebens S. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol, 8:982-997, 2014

Haselmann, V, Kurz A, Bertsch U, Hübner S, Olempska-Müller M, Fritsch J, Häsler R, Pickl A, Fritsche H, Annewanter F, Engler C, Fleig B, Bernt A, Röder C, Schmidt H, Gelhaus C, Hauser C, Egberts JH, Heneweer C, Rohde AM, Bögner C, Knippschild U, Röcken C, Adam, D, Walczak H, Schütze S, Janssen O, Wulczyn FG, Wajant H, Kalthoff H, Trauzold A. Nuclear death receptor TRAIL-R2 inhibits maturation of Let-7 and promotes proliferation of pancreatic and other tumor cells. Gastroenterology, 146:278-290, 2014

Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren, H, Vogel I, Krüger U, Becker T, Ebsen, M, Röcken C, Kabelitz D, Schäfer H, Sebens S. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer, 135:843-861, 2014

Helm O, Mennrich R, Petrick D, Goebel L, Freitag-Wolf S, Röder C, Kalthoff H, Röcken C, Sipos B, Kabelitz D, Schäfer H, Oberg HH, Wesch D, Sebens S. Comparative characterization of stroma cell and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS One, 9:e94357, 2014

Kabelitz D. Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human  T cells. Cell Mol Immunol, 11:117-119, 2014

Kalyan S, Chandrasasekaran V, Quabius ES, Lindhorst TK, Kabelitz, D. Neutrophil uptake of nitrogen-bisphoshonates leads to the suppression of human peripheral blood  T cells. Cell Mol Life Sci, 71:2335-46, 2014

Kalyan S, Huebbe P, Esatbeyoglu T, Niklowitz P, Côté HCF, Rimbach G, Kabelitz D. Nitrogen-bisphosphonate therapy is linked to compromised coenzyme Q10 and vitamin E status in postmenopausal women. J Clin Endocrinol Metab 99:1307-1313, 2014

Kalyan S, Kabelitz D. When neutrophils meet T cells: Beginnings of a tumultuous relationship with underappreciated potential. Eur J Immunol, 44:627-633, 2014

Kling C, Hedderich J, Kabelitz D. Lymphocyte immunotherapy (LIT) after recurrent IVF implantation failure: Results of a prospective observational trial. Giorn It Ost Gin, 36:513-518, 2014

Kott M, Elke G, Reinicke M, Winoto-Morbach S, Schädler D, Zick G, Frerichs I, Weiler N, Schütze S. Acid Sphingomyelinase serum activity predicts mortality in intensive care unit patients after systemic inflammation: A prospective cohort study. PLoS One, 9:e112323, 2014

Lettau M, Kliche S, Kabelitz D, Janssen O. The adapter proteins ADAP and Nck cooperate in T cell adhesion . Mol Immunol, 60:72-79, 2014

Lettau M, Voss M, Ebsen H, Kabelitz D, Janssen O. Differential protein-protein interactions of full length human FasL and FasL fragments generated by intramembrane proteolysis. Exp Cell Res, 320:290-301, 2014

Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F, Hippe HJ, Linkermann A, Wolf MJ, Rose-John S, Lüllmann-Rauch R, Adam D, Flögel U, Heikenwaelder M, Luedde T, Frey N. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodeling after myocardial infarction. Cardiovasc Res, 103:206-216, 2014

Oberg HH, Kellner C, Peipp M, Sebens S, Adam-Klages S, Gramatzki M, Kabelitz D, Wesch D. Monitoring circulating  T cells in cancer patients to optimize  T cell-based immunotherapy. Front Immunol, 5:643, 2014

Oberg HH, Peipp M, Kellner C, Sebens S, Krause S, Petrick D, Adam-Klages S, Röcken C, Becker T, Vogel I, Weisner D, Freitag-Wolf S, Gramatzki M, Kabelitz D, Wesch D. Novel bispecific antibodies increase  T cell cytotoxicity against pancreatic cancer cells. Cancer Res, 74:1349-1360, 2014

Peters C, Oberg HH, Kabelitz D, Wesch D. Phenotype and regulation of immunosuppressive V2-expressing  T cells. Cell Mol Life Sci, 71:1943-1960, 2014

Preuß S, Scheiermann J, Stadelmann S, Omam FD, Winoto-Morbach S, Lex D, von Bismarck P, Adam-Klages S, Knerlich-Lukoschus F, Wesch D, Held-Feindt J, Uhlig S, Schütze S, Krause MF. 18:1/18:1-Dioleoyl-phosphatidylglycerol prevents alveolar epithelial apoptosis and profibrotic stimulus in a neonatal piglet model of acute respiratory distress syndrome. Pulm Pharmacol Ther, 28:25-34, 2014

Quabius ES, Möller P, Haag J, Pfannenschmidt S, Hedderich J, Görögh T, Röcken C, Hoffmann M. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas. Int J Cancer, 134:1323-34, 2014

Sosna J, Voigt S, Mathieu S, Lange A, Thon L, Davarnia P, Herdegen T, Linkermann A, Rittger A, Ka-Ming Chan F, Kabelitz D, Schütze S, Adam D. TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci, 71:331-348, 2014

Steinhäuser C, Dallenga T, Tchikov V, Schaible UE, Schütze S, Reiling N. Immunomagnetic isolation of pathogen-containing phagosomes and apoptotic blebs from primary phagocytes. Curr Protoc Immunol, 105:14.36.1-14.36.26, 2014

Tchikov V, Fritsch J, Schütze S. Separation of magnetically isolated TNF receptosomes from mitochondria. Methods Enzymol, 535:327-349, 2014

Voigt S, Philipp S, Davarnia P, Winoto-Morbach S, Röder C, Arenz C, Trauzold A, Kabelitz D, Schütze S, Kalthoff H, Adam D. TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells. BMC Cancer, 14:74, 2014

Wesch D, Peters C, Siegers GM. Human gamma delta T regulatory cells in cancer: fact or fiction? Front Immunol, 5:598, 2014